End stage kidney disease. Chronic uraemia End stage kidney disease:•in allograft failure
Conditions
Interventions
Hemodialysate temperature in the second and third weeks, respectively, will decrease to 36 ºC and 35ºC and all patients (cross-over study) for three sessions by each temperature will be undergoing h
Sponsors
Vice Chancellor for Research and Technology,Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:patients that are in end stage renal disease and Minimum of three months before participating in the study are hemodialysis;None of the blood pressure-lowering drugs on the morning of dialysis are not used; Absence of cardiac disorders such as MI or having a pacemaker; No risk of severe anemia Hb<8 ; Absence of diabetic neuropathy (due to ortho-static hypotension in these patients) ;No one have cancer; Lack of thyroid disorders (due to temperature changes that may occur.) Exclusion criteria:The use of blood pressure decreasing agents before dialysis;Severe heart disorders such as unstable angina and MI occure during the study;Malignant disease such as cancer occure during the study; thyroid disorders occure during the study; Severe shivering, so that the patient may not be able to continue dialysis;Severe and uncontrollable vomiting.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Temperature. Timepoint: Before and after dialysis. Method of measurement: Oral Digital Thermometer.;Blood pressure and pulse. Timepoint: For the first, second, third hour and the end of dialysis. Method of measurement: With digital sphygmomanometer cuff.;Patient comfort. Timepoint: At the end of the third session. Method of measurement: VAS chart.;Hemodialysis adequacy. Timepoint: End of the third session. Method of measurement: Measurement of Urea & Creatinine before and after dialysis, according to a formula Daygr DOS 2. | — |
Secondary
| Measure | Time frame |
|---|---|
| Feeling cold and shivering. Timepoint: For first, second and third hour. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Farghadani
Hamedan University of Medical Sciences
Outcome results
None listed